Company / Operating Income
REGENXBIO Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$161.2M
FY2025
5-year range
-$268.1M / -$149.0M
FY2021-FY2025
Trend
+30.9%
vs FY2024
Sector context
#122 of 204
Health Care
What the data says
At -$161M, REGENXBIO Inc.'s operating income ranks #122 of 204 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from -$268M in FY2023 to $88M in FY2020.
Based on SEC 10-K filings.
-$161M in FY2025.
Improved from -$268M to -$161M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 204 in Health CareTop 60% of 204This company -$161.2M Sector average $107.8M
▼
-249.6% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 30.9% year-over-year.
- Ranks #122 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$161.2M | +30.9% |
| FY2024 | -$233.3M | +13.0% |
| FY2023 | -$268.1M | -2.0% |
| FY2022 | -$262.9M | -76.4% |
| FY2021 | -$149.0M | -269.1% |
| FY2020 | $88.1M | +216.1% |
| FY2019 | -$75.9M | -186.1% |
| FY2018 | $88.1M | +216.1% |
| FY2017 | -$75.9M | -1961.0% |
| FY2016 | -$3.7M | +22.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026